Skip to Main Content

Author Details

Qimin Zhan
Peking University Cancer Hospital
1989
371
68
PMIDPaper TitleJournal TitlePublished Year
36563680Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.Cancer Cell2023
37582812CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties.Signal Transduct Target Ther2023
37724257Precision medicine revolutionizes cancer diagnosis and treatment.Med Rev (2021)2023
37564101Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.Comput Struct Biotechnol J2023
37215526China: The role of botanical gardens in conservation.Innovation (Camb)2023
37279554Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma.Carcinogenesis2023
36584672Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.Cancer Cell2023
36763244Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.Sci China Life Sci2023
36563680Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.Cancer Cell2023
36873192PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy.Acta Pharm Sin B2023
37442756MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.Adv Sci (Weinh)2023
36693832Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.Signal Transduct Target Ther2023
37180834Aqueous-soluble components of sporoderm-removed <i>Ganoderma lucidum</i> spore powder promote ferroptosis in oral squamous cell carcinoma.Chin J Cancer Res2023
36923525Erratum: Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.Theranostics2023
37036437Long non-coding RNA colon cancer-associated transcript 1-Vimentin axis promoting the migration and invasion of HeLa cells.Chin Med J (Engl)2023
37582812CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties.Signal Transduct Target Ther2023
37724257Precision medicine revolutionizes cancer diagnosis and treatment.Med Rev (2021)2023
37564101Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.Comput Struct Biotechnol J2023
37215526China: The role of botanical gardens in conservation.Innovation (Camb)2023
37180834Aqueous-soluble components of sporoderm-removed <i>Ganoderma lucidum</i> spore powder promote ferroptosis in oral squamous cell carcinoma.Chin J Cancer Res2023
37442756MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.Adv Sci (Weinh)2023
37279554Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma.Carcinogenesis2023
37036437Long non-coding RNA colon cancer-associated transcript 1-Vimentin axis promoting the migration and invasion of HeLa cells.Chin Med J (Engl)2023
36923525Erratum: Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.Theranostics2023
36693832Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.Signal Transduct Target Ther2023
36584672Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.Cancer Cell2023
36873192PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy.Acta Pharm Sin B2023
36763244Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.Sci China Life Sci2023
35081867Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.Bioengineered2022
35706406Telomere is shortened in patients with irritable bowel syndrome in the Chinese population.J Gastroenterol Hepatol2022
36168622The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma.Theranostics2022
35962191Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC).Cell Mol Immunol2022
35449073Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).J Exp Clin Cancer Res2022
36352227Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.Nature2022
35643957PTBP1 promotes IRES-mediated translation of cyclin B1 in cancer.Acta Biochim Biophys Sin (Shanghai)2022
35498735Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Crucian Carp (<i>Carassius auratus gibelio</i>) Following Single and Multiple Oral Administration.Front Vet Sci2022
35691199The toxicokinetics and risk assessment of pyrethroids pesticide in tilapia (Oreochromis mossambicus) upon short-term water exposure.Ecotoxicol Environ Saf2022
35806310Integrative Analysis of miRNAs and Their Targets Involved in Ray Floret Growth in <i>Gerbera hybrida</i>.Int J Mol Sci2022
36272974Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma.Nat Commun2022
36207607A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy.Br J Cancer2022
35982900The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.Int J Biol Sci2022
35355934Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma.Chin J Cancer Res2022
35979619FAM135B sustains the reservoir of Tip60-ATM assembly to promote DNA damage response.Clin Transl Med2022
36252979China's Personal Information Protection Law.BMJ2022
37724298Understanding metabolic reprogramming in tumor microenvironment.Med Rev (2021)2022
37724078Welcome to your new journal: <i>Medical Review</i>.Med Rev (Berl)2022
35177820Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.Cell Res2022
35153295Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma.Signal Transduct Target Ther2022
35081867Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.Bioengineered2022
37724298Understanding metabolic reprogramming in tumor microenvironment.Med Rev (2021)2022
  • 1 - 50 of 742

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 1
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 2
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 1
Aidong Zhou
Southern Medical University
Career Start Year 2002
Number of shared co-authors 0
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 1
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Hye Jin You
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 2
Ming Zhan
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 1
Yan Liu
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 1
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 2
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 1

Collaborators

Yongmei Song
Shandong University of Traditional Chinese Medicine
Co-authored papers 71
Albert J Fornace
Co-authored papers 35
Liyan Xue
Xuzhou Central Hospital
Co-authored papers 25
Zitong Zhao
School of Pharmacy, Wannan Medical College
Co-authored papers 22
Dongxin Lin
Co-authored papers 8
Leilei Zheng
Co-authored papers 5
Xiaohang Zhao
Co-authored papers 5
Jun Wang
Zhongnan Hospital of Wuhan University
Co-authored papers 4
Minghui He
The First Affiliated Hospital, Sun Yat-sen University
Co-authored papers 4
Huanming Yang
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers 4
Robert J Coffey
Co-authored papers 3
Ruibin Xi
Co-authored papers 3
Bert Vogelstein
Co-authored papers 3
Sheue-Yann Cheng
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Kurt W Kohn
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Udo Kontny
Co-authored papers 3
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 2
Yan Zhang
Co-authored papers 2
Peter Kraft
Harvard T. H. Chan School of Public Health
Co-authored papers 2
Lee J Helman
Osteosarcoma Institute
Co-authored papers 2
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Co-authored papers 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Co-authored papers 2
Siqi Liu
The Second Hospital, Jilin University
Co-authored papers 2
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 2
Yike Li
Vanderbilt University Medical Center
Co-authored papers 2
Wen-Qiang Wei
Tianjin First Central Hospital, Nankai University
Co-authored papers 2
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Mitchell H Gail
Co-authored papers 2
Tao He
Co-authored papers 2
Yusen Liu
Co-authored papers 2
Release 1.2